BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21437762)

  • 1. Validated tools for evaluating opioid-induced bowel dysfunction.
    Olesen AE; Drewes AM
    Adv Ther; 2011 Apr; 28(4):279-94. PubMed ID: 21437762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.
    Drewes AM; Munkholm P; Simrén M; Breivik H; Kongsgaard UE; Hatlebakk JG; Agreus L; Friedrichsen M; Christrup LL
    Scand J Pain; 2016 Apr; 11():111-122. PubMed ID: 28850449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction.
    Leppert W
    Drug Des Devel Ther; 2015; 9():2215-31. PubMed ID: 25931815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid-induced bowel dysfunction in healthy volunteers assessed with questionnaires and MRI.
    Nilsson M; Poulsen JL; Brock C; Sandberg TH; Gram M; Frøkjær JB; Krogh K; Drewes AM
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):514-24. PubMed ID: 26795566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and treatment of constipation and fecal impaction in adults.
    Prather CM; Ortiz-Camacho CP
    Mayo Clin Proc; 1998 Sep; 73(9):881-6; quiz 887. PubMed ID: 9737226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-induced gastrointestinal dysfunction.
    Mehendale SR; Yuan CS
    Dig Dis; 2006; 24(1-2):105-12. PubMed ID: 16699269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation.
    Rentz AM; Yu R; Müller-Lissner S; Leyendecker P
    J Med Econ; 2009; 12(4):371-83. PubMed ID: 19912069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid-induced bowel dysfunction: pathophysiology and management.
    Brock C; Olesen SS; Olesen AE; Frøkjaer JB; Andresen T; Drewes AM
    Drugs; 2012 Oct; 72(14):1847-65. PubMed ID: 22950533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and impact of constipation and bowel dysfunction induced by strong opioids: a cross-sectional survey of 520 patients with cancer pain: DYONISOS study.
    Abramowitz L; Béziaud N; Labreze L; Giardina V; Caussé C; Chuberre B; Allaert FA; Perrot S
    J Med Econ; 2013 Dec; 16(12):1423-33. PubMed ID: 24102123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden.
    Panchal SJ; Müller-Schwefe P; Wurzelmann JI
    Int J Clin Pract; 2007 Jul; 61(7):1181-7. PubMed ID: 17488292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative care and pain: new strategies for managing opioid bowel dysfunction.
    Thomas JR; Cooney GA; Slatkin NE
    J Palliat Med; 2008 Sep; 11 Suppl 1():S1-19; quiz S21-2. PubMed ID: 18800914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polyethylene glycol (Macrogol)--an overview of its use in diagnosis and therapy of gastrointestinal diseases].
    Hammer HF; Hammer J; Gasche C
    Wien Klin Wochenschr; 2000 Jan; 112(2):53-60. PubMed ID: 10703152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a bowel function diary for assessing opioid-induced constipation.
    Camilleri M; Rothman M; Ho KF; Etropolski M
    Am J Gastroenterol; 2011 Mar; 106(3):497-506. PubMed ID: 21063394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of linaclotide for patients with chronic constipation.
    Lembo AJ; Kurtz CB; Macdougall JE; Lavins BJ; Currie MG; Fitch DA; Jeglinski BI; Johnston JM
    Gastroenterology; 2010 Mar; 138(3):886-95.e1. PubMed ID: 20045700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Symptom Severity and Quality of Life in Patients With Obstructive Defecation and Colonic Inertia.
    Chou AB; Cohan JN; Varma MG
    Dis Colon Rectum; 2015 Oct; 58(10):994-8. PubMed ID: 26347972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular diseases of the gastrointestinal tract. Specific disorders that often get a nonspecific diagnosis.
    Mathias JR; Clench MH
    Postgrad Med; 1995 Mar; 97(3):95-8, 101-2, 105-8. PubMed ID: 7877932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of opioid-induced gut dysfunction.
    Holzer P
    Expert Opin Investig Drugs; 2007 Feb; 16(2):181-94. PubMed ID: 17243938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal motility disorders.
    Abell TL; Werkman RF
    Am Fam Physician; 1996 Feb; 53(3):895-902. PubMed ID: 8594865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitude of Swiss physicians towards opioid-induced constipation: a national survey.
    Hess B; Bernardi M; Klotz HP
    Eur J Intern Med; 2011 Oct; 22(5):527-31. PubMed ID: 21925066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.